TG Therapeutics | TGTX - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
AbbVie USD 6.57B 2.82B 2026-06
Alaunos Therapeutics USD 354K 1.03M 2026-03
Amgen USD 13.99B 1.95B 2026-06
Ardelyx USD 31.21M 36.79M 2026-03
Arrowhead Research USD 19.68M 127.85M 2026-06
Bayer EUR 4.29B 1.44B 2026-06
Biogen USD 1.28B 2.1B 2026-06
Corcept Therapeutics USD 111.04M 2.3M 2026-06
Curis USD 10.14M 10.14M 2025-06
Gilead Sciences USD 7.63B 64M 2026-03
J&J USD 20.42B 1.27B 2026-06
Karyopharm Therapeutics USD 90.85M 30.31M 2026-03
Novartis USD 7.62B 739M 2026-06
Novavax USD 191.46M 36.9M 2026-06
PTC Therapeutics USD 1.05B 215.9M 2026-06
Puma Biotechnology USD 53.52M 1.14M 2025-09
Regeneron Pharmaceuticals USD 2.46B 506.8M 2026-06
Roche Holding CHF 7.55B 579M 2025-06
TG Therapeutics USD 612.25M 170.04M 2026-06
Verastem USD 181.68M 23.31M 2026-03
Vertex Pharmaceuticals USD 7.85B 605.7M 2026-06